Will Cigarettes Disappear in 10 Years?

TL;DR

Philip Morris International aims to phase out cigarettes within the next decade by focusing on smoke-free alternatives like IQOS. The company has invested over $10 billion in research and development, resulting in 27 million IQOS users worldwide. Despite skepticism, PMI is committed to transforming its business and reducing smoking-related harm.

Transcript

My name is Jacek Olczak. I am a Chief Executive  Officer of Philip Morris International. So, Philip Morris International for many years, has  been known as the cigarette maker, the global leader in the cigarette category. And for the  last 10 years, we've been known as the company which wants to transform its purpose fully to  “unsmoke the world”, ... Read More

Key Insights

• Philip Morris International is transitioning from cigarettes to smoke-free products.
• The company has invested over $10 billion in smoke-free product development.
• IQOS has 27 million users globally, showing significant adoption.
• PMI's goal is to phase out cigarettes entirely in the next decade.
• Skepticism exists about tobacco companies in scientific debates.
• PMI emphasizes the importance of behavioral change to reduce smoking.
• The company is also exploring healthcare and wellness product lines.
• PMI's transformation is unprecedented in scale within the tobacco industry.

Questions & Answers

Q: How is Philip Morris International planning to phase out cigarettes?

Philip Morris International plans to phase out cigarettes by focusing on smoke-free alternatives like IQOS. The company has invested over $10 billion in research and development to create products that are less harmful than traditional cigarettes. PMI's strategy involves encouraging smokers to switch to these alternatives, with the goal of eliminating cigarettes completely within the next decade.

Q: What is IQOS and how does it differ from traditional cigarettes?

IQOS is a smoke-free product developed by Philip Morris International. Unlike traditional cigarettes, which burn tobacco, IQOS heats tobacco to release a nicotine-containing vapor without combustion. This process significantly reduces the harmful chemicals typically found in cigarette smoke, making it a less harmful alternative for smokers who cannot quit nicotine entirely.

Q: Why is there skepticism about tobacco companies in scientific debates?

Skepticism about tobacco companies in scientific debates stems from their history of downplaying the health risks of smoking. Many people question the motives and credibility of these companies when they participate in discussions about public health. Despite this skepticism, companies like Philip Morris International are investing heavily in scientific research to develop safer alternatives to traditional cigarettes.

Q: What are the key challenges in transitioning smokers to smoke-free products?

The key challenges in transitioning smokers to smoke-free products include overcoming skepticism, changing long-established behaviors, and convincing smokers of the benefits of these alternatives. While developing less harmful products is crucial, encouraging smokers to make the switch requires significant effort in education and addressing ingrained habits and perceptions about smoking.

Q: How has Philip Morris International's business model evolved over the past decade?

Over the past decade, Philip Morris International has evolved its business model from focusing solely on traditional cigarettes to prioritizing smoke-free alternatives. This shift includes significant investments in research and development, resulting in products like IQOS. The company's goal is to reduce the harm caused by smoking and ultimately phase out cigarettes entirely, aligning with changing consumer demands and advancements in science.

Q: What impact has the introduction of IQOS had globally?

The introduction of IQOS has had a significant global impact, with 27 million users adopting the smoke-free product. This adoption demonstrates a growing acceptance of alternatives to traditional cigarettes. IQOS's success highlights the potential for smoke-free products to reduce smoking-related harm and supports Philip Morris International's vision of a future without cigarettes.

Q: What future opportunities is Philip Morris International exploring beyond smoke-free products?

Beyond smoke-free products, Philip Morris International is exploring opportunities in the healthcare and wellness sectors. The company is leveraging its scientific and technological capabilities to develop new product lines that complement its smoke-free initiatives. This diversification aims to address broader health and wellness needs, positioning PMI as a leader in both tobacco harm reduction and general health improvement.

Q: What role does scientific research play in Philip Morris International's strategy?

Scientific research is central to Philip Morris International's strategy, guiding the development of smoke-free products and ensuring their safety and efficacy. The company has invested heavily in research and development, employing over 1,500 scientists globally. This focus on science supports PMI's commitment to reducing smoking-related harm and achieving its goal of phasing out cigarettes in favor of safer alternatives.

Summary & Key Takeaways

• Philip Morris International is actively working to eliminate cigarettes by promoting smoke-free alternatives like IQOS. With a $10 billion investment in research and development, PMI has successfully attracted 27 million users to its smoke-free products. The company's vision is to completely phase out cigarettes within the next decade, despite ongoing skepticism about tobacco companies' roles in scientific discussions.

• The shift from traditional cigarettes to smoke-free alternatives is a significant part of PMI's strategy. The company aims to address the harm caused by smoking through innovative products, emphasizing the importance of behavioral changes among smokers. PMI's transformation involves a large-scale commitment to science and technology, positioning it as a leader in the tobacco industry's evolution.

• As PMI continues its journey towards a smoke-free future, it also explores opportunities in healthcare and wellness sectors. The company believes that reducing smoking rates globally will benefit not only smokers but also their families and society as a whole. PMI's ambitious transformation reflects its dedication to public health and adapting to changing consumer demands.